Intellia Therapeutics (NTLA) PT Lowered to $44 at Baird
Tweet
Share
E-mailGet Alerts NTLA Hot Sheet
Price: $12.14 +1.93%
Rating Summary:
23 Buy, 9 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Rating Summary:
23 Buy, 9 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Join SI Premium – FREE
Baird analyst Jack Allen lowered the price target on Intellia Therapeutics (NASDAQ: NTLA) to $44.00 (from $48.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- SM Prime Holdings, Inc (SMPH:PM) (SPHXF) PT Lowered to PHP21 at JPMorgan
- Candel Therapeutics Inc. (CADL) PT Raised to $15 at Freedom Broker
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
